A booster dose enhances immunogenicity of the COVID-19 vaccine candidate ChAdOx1 nCoV-19 in aged mice

BACKGROUND: The spread of SARS-CoV-2 has caused a worldwide pandemic that has affected almost every aspect of human life. The development of an effective COVID-19 vaccine could limit the morbidity and mortality caused by infection and may enable the relaxation of social-distancing measures. Age is o...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva-Cayetano, Alyssa, Foster, William S., Innocentin, Silvia, Belij-Rammerstorfer, Sandra, Spencer, Alexandra J., Burton, Oliver T., Fra-Bidó, Sigrid, Le Lee, Jia, Thakur, Nazia, Conceicao, Carina, Wright, Daniel, Barrett, Jordan, Evans-Bailey, Nicola, Noble, Carly, Bailey, Dalan, Liston, Adrian, Gilbert, Sarah C., Lambe, Teresa, Linterman, Michelle A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cell Press 2021
Materias:
Clinical and Translational Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833318/
https://www.ncbi.nlm.nih.gov/pubmed/33521747
http://dx.doi.org/10.1016/j.medj.2020.12.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833318/
https://www.ncbi.nlm.nih.gov/pubmed/33521747
http://dx.doi.org/10.1016/j.medj.2020.12.006

Ejemplares similares